Pharmacological Group: Antiarritmics, Active Principle: Adenosine, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 3, Unit: Mg / Ml, Volume: 2Ml, Ampolo: Unpalested: Non -Applicable, Pharmacological Group: Antiemetics And Procinetic, Active Principle: Pharmamide Hydrochloride: Pharmaceutical Form, Concentration / Dosage: 2, Unit: Mg, Volume: Not Applied, Presentation: Not Applicable, Pharmacological Group: Nutrition And Parenteral Hydroelectrolytic Replacement, Active Principle: Olas Adult Zinc Sulfate (5Mg); Pentaidrated Sulphate (1, 6); Monohydrate Manganese Sulfate (0, 8 Mg); Hexahydrate Chromic Chloride (20 Mcg), Concentration/Dosage: N/A, Unit: N/A, Volume: 2 Ml, Accessory: N/A, Pharmacological Group: Nourishment And Pasteral Hydroelectrolytic Replacement, Active Principle: Pediatric Oligolements - Heptahydrate Zinc Sulfate (8, 8 Mg), Pentadrated Sulfate (1, 6 Mg); Monohydrate Manganese Sulfate (123, 04 Mcg); Hexahydrate Chromic Chloride (20, 05 Mcg), Volume: 4 Ml, Form Supply: Unit, Pharmacological Group: Constipative And Regulators Of Intestinal Flora, Active Principle: Saccharomyces Boulardii, Pharmaceutical Form: Lyophilized, Concentration/Dosage: 200, Volume: N/A, Presentation: Envelope, 10/09/2025, Group Pharmacological: Antibacterials, Active Principle: Sulfametoxazole+Trimetopry, Concentration / Dosage: 80+16, Unit: Mg+Mg / Ml, Volume: 5Ml
